Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Abstract Background To improve outcomes in patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention remain an unmet clinical need. The study aimed to evaluate the efficacy and safety of G2-DESs and BP-DESs in patients with and without DM in a single center in China. Methods...

Full description

Bibliographic Details
Main Authors:	Xiao-Fang Tang, Yuan-Liang Ma, Ying Song, Jing-Jing Xu, Yi Yao, Chen He, Huan-Huan Wang, Ping Jiang, Lin Jiang, Ru Liu, Zhan Gao, Xue-yan Zhao, Shu-Bin Qiao, Yue-Jin Yang, Run-Lin Gao, Bo Xu, Jin-Qing Yuan
Format:	Article
Language:	English
Published:	BMC 2018-08-01
Series:	Cardiovascular Diabetology
Subjects:	Diabetes mellitus Second-generation drug-eluting stent Biodegradable polymer drug-eluting stent Target lesion revascularization
Online Access:	http://link.springer.com/article/10.1186/s12933-018-0758-0

Similar Items

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
by: Ryota Kakizaki, et al.
Published: (2020-10-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
by: Kong-Yong Cui, et al.
Published: (2018-01-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

5 year-effectiveness of paclitaxel drug-eluting balloon for coronary in-stent restenosis in a real-world registry
by: José Antonio Linares Vicente, et al.
Published: (2019-05-01)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
by: Alberto Chisari, et al.
Published: (2016-09-01)

Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
by: Yuan-Liang Ma, et al.
Published: (2018-01-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

The fate of small side branches following drug eluting stent implantation
by: Demet Ozkaramanli Gur, et al.
Published: (2016-09-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
by: Wonsuk Choi, et al.
Published: (2019-07-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
by: Damian Maciejewski, et al.
Published: (2019-09-01)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
by: Takeshi Ijichi, et al.
Published: (2021-06-01)

Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation
by: Pritam Patil, et al.
Published: (2014-03-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

One year follow-up cardiovascular outcomes of Coraxel brand paclitaxel eluting stents: a single center experience
by: Fatih Levent, et al.
Published: (2017-06-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
by: Ganesh Paramasivam, et al.
Published: (2019-11-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01)

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture
by: Dong-Ru Ho, et al.
Published: (2021-05-01)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
by: Leos Pleva, et al.
Published: (2017-06-01)

Clinical outcomes of percutaneous coronary intervention with drug eluting stents in diabetic patients
by: Pedarzadeh A., et al.
Published: (2007-10-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01)

Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis
by: Soonchan Park, et al.
Published: (2013-02-01)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
by: Gurpreet Singh, MD, et al.
Published: (2019-10-01)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
by: Lulu Liu, et al.
Published: (2018-03-01)

Clinical analysis of permanent, biodegradable and polymer-free drug eluting stent in treatment of unprotected left main coronary artery disease
by: ZHOU Denglu, et al.
Published: (2019-03-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01)

Role of Second-Generation Drug-Eluting Stents and Bypass Grafting in Coronary Artery Disease: A Systematic Review and Meta-analysis
by: Linjuan Guo, MD, et al.
Published: (2017-02-01)

Comparison of drug-eluting and bare-metal stents in patients with saphenous vein graft stenosis
by: Ahmed Zayed, et al.
Published: (2020-01-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

Drug diffusion and biological responses of arteries using a drug-eluting stent with nonuniform coating
by: Saito N, et al.
Published: (2016-03-01)